Fluorescence agents: Imaging biological activity in vivo
Quantitative Tomography: FMT 2005 Imaging System
news
 VisEn Launches  New VivoTag 680 XL  Molecular Imaging Label

Enables Expanded Imaging Applications of Biomarkers in Research and Drug Development

more
news
 VisEn Acquires Key  Fluorescence Agent  Intellectual Property  Portfolio and Technology  Platforms From Bayer  Schering Pharma

Consolidates the Leading IP Positions and Technologies In Fluorescence In Vivo Imaging Agents

more
events
 Upcoming Events  & Workshops
February 25: Texas Medical Center, Life Sciences Exhibits Event (LSE), Houston, TX
March 24: University of Georgia; Life Sciences Exhibit Event (LSE), Athens, GA
March 31:  University of Pittsburgh; Life Sciences Exhibit Event (LSE), Pittsburgh, PA
April 8:  Case Western Reserve University; Life Sciences Exhibit Event (LSE), Cleveland, OH
April 17-21:  American Association for Cancer Research (AACR) 101st Annual Meeting 2010, Washington, DC
April 24-28:  Experimental Biology 2010, Anaheim, CA
April 28: Abbott Pharmaceuticals/UMASS Medical School; Life Sciences Exhibits Event (LSE), Worcester, MA
May 4-6: 4th International Congress on Biomarkers of Chronic Disease; Riyadh, Saudi Arabia
May 5: Duke University, Life Sciences Exhibits Event (LSE), Durham, NC
more

VisEn is the leader is quantitative molecular imaging for small animal imaging and quantitative preclinical results. Our FMT 2500TM LX and FMT 1500TM quantitative tomography in vivo imaging systems are the leading instruments for generating true 3D quantitative data to the picomole for deep tissue imaging in vivo. Our range of 30+ fluorescent in vivo imaging agents, labels and nanoparticles provide preclinical researchers with the largest range of robust imaging agents for use on our FMT systems as well as most other planar fluorescent imaging systems.